FindTrial
Sign In

To evaluate changes in its DNA and RNA makeup in tumor in hormone therapy resistant breast cancer

Multi-Omics Analysis to Decipher Mechanisms of Hormone Resistance in Breast Cancerâ??

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2017/11/010553
Enrollment
390
Registered
2017-11-17
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Locally advance breast cancer Metastatic Breast Cancer

Interventions

Intervention1: Not applicable: Only biopsy will be collected.

Sponsors

Department of Biotechnology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Locally advanced breast cancer and Metastatic breast cancer

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
To identify major pathways through which a tumour becomes resistant to endocrine therapyTimepoint: At first relapse—

Secondary

MeasureTime frame
NATimepoint: NA—

Countries

India

Contacts

Public ContactYogesh Kembhavi

Tata Memorial Centre

sudeepgupta04@yahoo.com022-24177201

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 9, 2026